| 摘要 |
Urea compounds disclosed herein increase HDL-C levels and as such can be used in prevention and treatment of atherosclerosis, myocardial infarction and related conditions such as peripheral vascular disease and ischemic stroke hypoalphalipoproteinemia.
|
